Fundz

Immunophotonics reported raising $3.45 Million in an initial SEC Form D filing, from an offering of $6.5 Million

PRIVATEFeb 14, 2023$3.5M of $6.5M raised

Amount Raised

$3.45 Million

$3.45 Million sold, per SEC Form D (first sale Jan 6, 2023)

Round Type

Seed

St. LouisHealthcare

Quick answer

Immunophotonics raised $3.45 Million in a Seed round, dated January 6, 2023. Immunophotonics is based in St. Louis, Missouri, United States.

How much did Immunophotonics raise?
Immunophotonics raised $3.45 Million in a Seed round on January 6, 2023.
What does Immunophotonics do?
Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity.
Where is Immunophotonics based and how big is it?
Immunophotonics is based in St. Louis, Missouri, United States. Fundz records about 18 employees.
Who are the decision-makers at Immunophotonics?
Fundz holds 1 contact at Immunophotonics, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Immunophotonics that raised within 45 days of this round, from Fundz verified event records.

  • Slipstream Solutions raised $650K (Seed) on February 17, 2023.
  • PathwaysGI raised $350K (Seed) on February 17, 2023.
  • Endogenex raised $9.2M on February 17, 2023.
  • Imagen Dental Partners raised $788K (Seed) on February 17, 2023.
  • VenatoRx Pharmaceuticals, Inc. raised $15M on February 17, 2023.
  • Zyus raised $19K (Pre-Seed) on February 16, 2023.

Who to call at Immunophotonics, and when

A new round usually means Immunophotonics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immunophotonics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunophotonics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunophotonics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunophotonics

Location

4340 Duncan Ave.

St. Louis, Missouri, United States

About

Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunophotonics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLu A., Executive Officer, Director, Promoter hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Immunophotonics's next move

See what Strategic adds

Immunophotonics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.